NovaMed Pharmaceuticals Inc. Report issue

For profit Phase 3
Founded: Shanghai China (2005)
Status: Acquired by SciClone Pharmaceuticals (2011)

Organization Overview

First Clinical Trial
2010
NCT01224353
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

alpha-lipoic acid (1 trial)

budesonide (rhinocort) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 3)

Polyneuropathies (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2